The U.S. has gone on a tariff announcement spree – from general tariffs to secondary tariffs, to now tariffs on pharmaceuticals and even the movie industry. But despite tariffs on pharma imports to the U.S. why don’t Indian pharma firms and investors seem in panic, as stock prices steadied after an initial dip?
